Clinical Briefings™ The Cutting Edge of Sleep Science: Emerging Treatments in Insomnia

Released On
March 20, 2020

Expires On
March 20, 2021

Media Type
Internet

Completion Time
60 minutes

Specialty
Neurology, Primary Care, Psychiatry

Topic(s)
Sleep Medicine

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by Physicians’ Education Resource®, LLC.

Supported by an educational grant from Eisai Inc.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses — 1.0 contact hours.

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This online educational activity is directed toward primary care physicians, neurologists, nurse practitioners (NPs), physician assistants (PAs), nurses, and other health care professionals who are involved in the treatment of insomnia.

Statement of Need/Program Overview

This online activity is designed to provide a concise and focused overview on an important clinical topic and includes information on the complex disease pathophysiology and etiology of insomnia, the clinical presentation and diagnostic evaluation of patients with insomnia, and the efficacy and safety of therapies recommended for the management of chronic insomnia. The engaging, multimedia format of this program includes audio commentary from an expert thought leader integrated with text-based elements.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate the impact of insomnia on the patient’s quality of life
  • Recognize strategies for adequate diagnosis of insomnia
  • Assess the efficacy and safety data from clinical trials of approved and emerging agents
  • Develop patient-centered treatment approaches for optimization of patient outcomes

Faculty

Paul P. Doghramji, MD, FAAFP

Senior Family Physician
Collegeville Family Practice
Medical Director of Health Services
Ursinus College
Collegeville, PA

Accreditation Statement

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Disclosures of Conflicts of Interest

Paul P. Doghramji, MD, FAAFP

  • Consultant: Eisai Inc., Allergan, AstraZeneca
  • Stock/Shareholder: Pfizer Inc.

Disclosure Statement

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Instructions for Participation and Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, “Educational Content/ Audio” will be available for your reference.
  • In order to receive a CME/CE Certificate, you must complete the activity.
  • Complete the Posttest and the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE Certificate upon completion of these steps.

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser.

Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.

Disclosure of Unlabeled Use

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or the company that provided commercial support.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.